ClinicalTrials.gg

Gingivitis clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 631 studies for Gingivitis across more than 10 countries. 107 are recruiting or about to start. 419 of them are mainly about Gingivitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

ClinicalTrials.gov finds 695 studies for Gingivitis. How that becomes 630 here

This page counts the studies the registry files under Gingivitis, and those it files under no condition that list Gingivitisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 695Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −16List Gingivitis as a condition, but the registry did not file them under itMost often written as “Plaque Induced Gingivitis” (6), “Dental Plaque Induced Gingivitis” (2), and “Gingivitis Infection” (2). The registry filed them under other conditions only, most often Dental Plaque (10) and Plaque, Amyloid (4).
  3. −49Match it another way37 name it in the title, 2 in a keyword, and 10 by a synonym or other text the search reads.
  4. 630The count on this page23 of them list Gingivitis in their own words; the registry filed them under no condition.

Status

Completed
448
Recruiting
53
Not yet recruiting
46
Status unknown
44
Active, not recruiting
18
Withdrawn
8

Phase

Phase 3
56
Phase 2
49
Phase 4
48
Phase 1
22
Early Phase 1
8

Where

United States
127
Turkey
96
Italy
32
Brazil
23
Canada
22
Egypt
21

Who develops what

Add Gingivitis to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 24 programs from 4 companies, 17 with this as their studies’ main aim; 5 with a live phase 3 study; 4 primary completions in the next 12 months. Compare Colgate Palmolive, HALEON and Procter and Gamble here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
fluorophosphateRecent, repeated
Evidence
  • NCT07842991 · Colgate Palmolive · Phase 3 · live · comparator · “Colgate Cavity Protection Toothpaste” · registered Sep 2026
  • NCT07499115 · Colgate Palmolive · Phase 3 · live · comparator · “Colgate Cavity Protection Toothpaste” · registered Mar 2026
  • NCT07458464 · Colgate Palmolive · Phase 3 · comparator · “0.76% Sodium Monofluorophosphate (Na MFP) toothpaste” · registered Mar 2026
  • NCT07398846 · Colgate Palmolive · Phase 3 · comparator · “0.76% Sodium Monofluorophosphate (Na MFP) toothpaste” · registered Jan 2026
  • NCT07158112 · Procter and Gamble · Phase 4 · live · comparator · “Sodium monofluorophosphate dentifrice” · registered Aug 2025
GlaxoSmithKline40% of its industry studies28 studies
Sodium FluorideRecent, repeated
Evidence
  • NCT07842991 · Colgate Palmolive · Phase 3 · live · comparator · “67% Bicarbonate with NaF (1400 F)” · registered Sep 2026
  • NCT07807397 · Colgate Palmolive · Phase 4 · live · background · “sodium fluoride Mouthwash” · registered Sep 2026
  • NCT07263698 · Colgate Palmolive · Phase 3 · comparator · “sodium fluoride Mouthwash” · registered Nov 2025
  • NCT07211061 · Procter and Gamble · Phase 4 · comparator · “Sodium Fluoride Dentifrice” · registered Sep 2025
GlaxoSmithKline69% of its industry studies24 studies

4 more in limited or earlier use — sign in to see them, free.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

In phase 3Company
Silica Free Meridol☆ Track1 live phase-3 study: NCT07842978Colgate Palmolive

The 1 in phase 3 with the nearest primary completion, of 24 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (4)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • Nov 2026 est.Colgate SNaP Total 10/10, 1.5 Taurate · Colgate Palmolive · Phase 3 named, not the main aimNCT07605338 To Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis. — primary endpoint: Loe-Silness Gingival Index · 85 enrolled
  • Jan 2027 est.0.45% SnF HW with NaF (1450 F) · Colgate Palmolive · Phase 3 named, not the main aimvs Sodium Fluoridevs fluorophosphatevs BicarbonatesNCT07842991 Clinical Evaluation of a Toothpaste for Dental Plaque Reduction and Prevention of Gum Problems — primary endpoint: Lobene Modified Gingivitis Assessment · 120 enrolled
  • Apr 2027 est.Silica Free Meridol · Colgate Palmolive · Phase 3 main aimNCT07842978 Clinical Study Examining the Control of Plaque and Gingivitis — primary endpoint: Gingivitis Assessment · 135 enrolled

1 more — sign in to see them all, free.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Gingivitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Coming up

48studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 53 Gingivitis studies recruiting now, 15 (28%) set no upper age limit and 36 (68%) stop at 75 or younger. 11 (21%) take children under 18. 5 (9%) are for women only and 0 (0%) for men only; 35 (66%) take healthy volunteers.

Recruiting studies that take each age, of 53
AgeWomenMen
104 (8%)3 (6%)
1846 (87%)41 (77%)
3042 (79%)37 (70%)
4042 (79%)37 (70%)
5039 (74%)36 (68%)
6537 (70%)34 (64%)
7517 (32%)14 (26%)
8517 (32%)14 (26%)

Across all 631 studies, recruiting or not: 70% stop at 75 or younger and 54% at 65; 19% take children; 5% are for women only and 1% for men only; 72% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Gingivitis studies take

Of 35 phase 3 interventional studies under Gingivitis, half reached primary completion within 3 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 14 mo2–7 · 11 studies——
Phase 22 mo1–15 · 16 studies——
Phase 33 mo2–6 · 35 studies3 mo2–6 · 23 studies—
Phase 43 mo2–4 · 25 studies——
Interventional, no phase7 mo3–15 · 257 studies3 mo1–5 · 53 studies9 mo4–18 · 204 studies
Observational12 mo5–25 · 30 studies—12 mo5–25 · 30 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 631. Browse all 631 → or search them.